Do intracrine mechanisms regulate aromatase expression?

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 447-452

  Simpson, Evan ^a   Jones, Margaret ^a   Davis, Susan ^b   Rubin, Gary ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN;

ADIPOSE TISSUE; ALZHEIMER DISEASE; BODY MASS; BONE MINERALIZATION; BREAST CANCER; CONFERENCE PAPER; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MALE; MENOPAUSE; OSTEOPOROSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

ANIMALS; AROMATASE; ESTROGENS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PROTEIN PRECURSORS;

EID: 0032978106     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00067-9     Document Type: Conference Paper

References (40)

1. E.R. Simpson, Y. Zhao, V.R. Agarwal, M.D. Michael, S.E. Bulun, M.M. Hinshelwood, S. Graham-Lorence, T. Sun, C.R. Fisher, C.R. Mendelson, Aromatase expression in health and disease. Rec. Prog. Horm. Res. (1997) 185-213.
2. Bulun S.E., Simpson E.R. Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J. Clin. Endocrinol. Metab. 78:1994;428-432.
3. Agarwal V.R., Bulun S.E., Leitch M., Rohrich R., Simpson E.R. Use of alternative promoters to express the aromatase cytochrome P450 ((CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endo. Metab. 81:1996;3843-3849.
4. Zhao Y., Nichols J.E., Bulun S.E., Mendelson C.R., Simpson E.R. Aromatase P450 gene expression in human adipose tissue: Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J. Biol. Chem. 270:1995;16,449-16,457.
5. Zhao Y., Nichols J.E., Valdez R., Mendelson C.R., Simpson E.R. Tumor necrosis factor-? stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol. Endocrinol. 10:1996;1350-1357.
6. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase gene). Endocrinology. 150:1996;S51-S57.
7. Shozu M., Zhao Y., Simpson E.R. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene. Endocrinology. 138:1997;5125-5135.
8. Shozu M., Simpson E.R. Aromatase expression of human osteoblast-like cells. Mol. Cell. Endocrinol. 139:1998;117-129.
9. Labrie F., Belanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not affected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 82:1997;2403-2409.
10. E.R. Simpson, S.R. Davis, Why do the clinical sequelae of estrogen deficiency affect women more frequently than men? J. Clin. Endocrinol. Metab. (1998).
11. Bruch H.R., Wolf L., Budde R., Romalo G., Schweikert H.U. Androstenedione metabolism in cultured human osteoblast-like cells. J. Clin. Endocrinol. Metab. 75:1992;]101-105.
12. Jakob F., Hormann D., Seufert J., Schneider D., Kohrle J. Expression and regulation of aromatase cytochrome P450 in THP-1 human myeloid leukemia cells. Mol. Cell. Endocrinol. 110:1995;27-33.
13. F. Bayard, S. Clamens, G. Delsol, N. Blaes, A. Maret, J.C. Faye, Oestrogen biosynthesis, ostrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells. Ciba Found Symp. (1995) 191: 122-132.
14. Murakami H., Sasano H., Satoh A., Satomi S., Nagura H., Harada N. Aromatase in human aortic tissue. Proceedings of 79th Annual Meeting Endocrinology Society of Minneapolis 1998, MN. 1998;212.
15. Naftolin F., Ryan K.J., Davies I.J., Reddy V.V., Flores F., Petro Z., Kuhn M., White R.J., Takaoka Y., Wolin L. The formation of estrogens by central neuroendocrine tissues. Rec. Prog. Horm. Res. 31:1975;295-319.
16. Siiteri P.K., MacDonald P.C. Role of extraglandular estrogen in human endocrinology. Greep R.O., Astwood E.B. Handbook of Physiology. vol. 2:1973;619-629 American Physiological Society, Washington, DC.
17. Melton L.J. Epidemiology of spinal osteoporosis. Spine. 22:1997;2S-11S.
18. Huang Z., Hankinson S.E., Colditz G.A., Stampfner M.J., Hunter D.J., Manson J.E., Hennekens C.H., Rosner B., Speizer F.E., Willett W.C. Dual effects of weight and weight gain on breast cancer risk. JAMA. 278:1997;1407-1411.
19. Tsia-Morris C.H., Aquilana D.R., Dufau M.L. Cellular localization of rat testicular aromatase activity during development. Endocrinology. 116:1985;38-46.
20. Hemsell D.L., Grodin J.M., Brenner P.F., Siiteri P.K., MacDonald P.C. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J. Clin. Endocrinol. Metab. 38:1974;476-479.
21. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80:1995;3689-3698.
22. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. New Engl. J. Med. 337:1997.
23. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New Engl. J. Med. 331:1994;1056-1061.
24. Oz O.K., Fisher C.R., Graves K.N., Nanu L., Zerwekh J., Simpson E.R. Alterations in bone histomorphometry and growth in aromatase deficient (ArKO) mice. Proceedings of 80th Annual Meeting US Endocrinology Society of New Orleans, LA. 1998;61.
25. Yaffe K., Sawaya G., Lieberburg L., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 279:1998;688-695.
26. Labrie F., Belanger A., Luu-The V., Labrie C., Simond J., Cusan L., Gomez J.L., Candas B. DHEA and the intracine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids. 63:1998;322-328.
27. Labrie F., Belanger A., Cusan L., Gomez J.L., Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab. 82:1997;2396-2402.
28. Sasano H., Frost A.R., Saitoh R., Harada N., Poutanen M., Vihko R., Bulun S.E., Silverberg S.G., Nagura H. Aromatase and 17?-hydroxysteroid dehydrogenase Type 1 in human breast carcinoma. J. Clin. Endocrinol. Metab. 81:1996;4042-4046.
29. Sasano H., Uzuki M., Sawai T., Nagura H., Matsunaga G., Kashimoto O., Harada N. Aromatase in human bone tissue. J. Bone Mineral Res. 12:1997;1416-1423.
30. Corbould A.M., Judd S.J., Rodgers R.J. Expression of types 1, 2 and 3. Mbeta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. J. Clin. Endocrinol. Metab. 83:1998;187-194.
31. Raisz L.G., Wiita B., Artis A. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J. Clin. Endocrinol. Metab. 81:1995;37-43.
32. Davis S.R., McCloud P.I., Strauss B.J.G., Burger H.G. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:1995;227-236.
33. Spiegelman B.M. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes. 47:1998;507-514.
34. Hotamisligil G.S., Shargil N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor?: direct role in obesity-linked insulin resistance. Science. 259:1993;87-91.
35. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 389:1997;610-614.
36. Bruning P.F., Bonfrer J.M.G., von Noord P.A.H., Hart A.A.M., de Jong-Bakker M., Nooijen W.J. Insulin resistance and breast-cancer risk. Int. J. Cancer. 52:1992;511-516.
37. Collaborative re-analysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,441 women without breast cancer. Lancet. 350:1997;1047-1059.
38. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., De la Londe L., Talbi M., Maloche C. Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 81:1996;1460-1464.
39. Service R.F. New role for estrogen in cancer? Science. 279:1998;1631-1633.
40. Harris R.E., Nauboodim K.K., Farrar W.B. Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology. 1:1996;203-205.